Effects of inhaled fluticasone propionate and oral prednisolone on lymphocyte β2-adrenoceptor function in asthmatic patients

Chest

Volumn 109, Issue 2, 1996, Pages 343-347

  Tan, Kia S ^a   Grove, Alison ^a   Cargill, Robert I ^a   McFarlane, Lesley C ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

asthma; inhaled fluticasone; prednisolone; 2 adrenoceptor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CORTICOSTEROID; CYCLIC AMP; FLUTICASONE PROPIONATE; HYDROCORTISONE; ISOPRENALINE; LYMPHOCYTE RECEPTOR; PREDNISOLONE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0030040968     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.2.343     Document Type: Article

References (25)

1. British Thoracic Society Research Unit of the Royal College of Physicians of London King's Fund Centre. National asthma campaign guidelines for management of asthma in adults: I. Chronic persistent asthma. BMJ 1990; 301:651-53
2. 2-adrenoceptors: accelerated restoration of beta-adrenergic responses by prednisolone and ketotifen. J Clin Invest 1985; 76:1096-1101
3. 2-bronchodilators. Eur J Clin Pharmacol 1988; 34:145-50
4. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-43
5. Phillips GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990; 84(suppl A):19-23
6. Hogger P, Rohdewald P. Binding kinetics of fluricasone propionate to the human glucocorticoid receptor. Steroids 1994; 59:597-602
7. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84(suppl A):25-9
8. Selroos O, Hulme M. Effect of a Volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroid from a metered-dose inhaler and dry powder inhaler. Thorax 1991; 46:891-94
9. Pedersen S, Steffensen G, Ohlsson SV. The influence of orally deposited budesonide after inhalation from a turbohaler. Br J Clin Pharmacol 1993; 36:211-14
10. Lipworth RJ. New perspectives on inhaled drug delivery and systemic bioactivity [editorial]. Thorax 1995; 50:105-10
11. Grahnen A, Eckernas SA, Brundin RM, et al. An assessment of the systemic activity of single doses of inhaled fluricasone propionate in healthy volunteers. Br J Clin Pharmacol 1994; 38:521-25
12. Grove A, Allam C, McFarlane LC, et al. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol 1994; 38:527-32
13. Boe J, Bakke P, Rodolen T, et al. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Eur Respir J 1994; 7:2179-84
14. 2-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J Clin Endocrinol Metab 1980; 51:599-605
15. 2-adrenergic receptor in human neutrophils: modulation by corticosteroid. J Clin Endocrinol Metab 1981; 53:703-38
16. 2-receptor function in the airways and adrenal responsiveness in bronchial asthma. Eur J Clin Pharmacol 1988; 34:577-83
17. Lipworth BJ, Struthers AD, McDevitt DG. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis 1989; 140:586-92
18. Newnham DM, McDevitt DG, Lipworth BJ. Bronchodilator subsensitivity after chronic dosing with eformorterol in patients with asthma. Am J Med 1994; 97:29-37
19. 2-adrenoceptor responses after regular twice dairy treatment with eformoterol dry powder in asthmatic patients. Thorax 1995; 50:497-504
20. Sears MR, Taylor RD, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336:1391-96
21. Van Schayck CP, Visch MB, Van Herwaarden CLA, et al. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by desensitization to salbutamol. J Allergy Clin Immunol 1990; 86:793-800
22. Van Sehayck CP, Dompeling E, Van Herwaarden CLA, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ 1991; 303:1426-31
23. Paggiaro PL, Dente FL, Vagagini B, et al. Salbutamol plus beclomethasone dipropionate but not salbutamol alone, completely prevent early and late asthmatic responses to allergen. Respir Med 1991; 85:401-06
24. Waalkens HJ, Gerritsen J, Koeter GH, et al. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow. Thorax 1991; 46:499-503
25. Kerstjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327:1413-19